The anti-OFD1 and anti-Ofd1, were generated against the human full-length OFD1 protein (NM_003611) and a portion of the murine Ofd1 homologous protein (NM_177429 Aa 461–884), respectively, and were previously described60 (link). All other antibodies used in this study are commercially available and are listed below. From Santa Cruz Biotechnology: eIF3G (R-20 sc-16362), eIF3B (H-300 sc-28857), GAPDH (6C5 sc-32233), GH (sc-10364), VPS39 (D15 sc-104759), NET1 (H-70 sc50392), IgG mouse (sc-2025), IgG rabbit (sc-2027). From Cell Signaling Technology: eIF4E (9742), eIF4G (2498), phosphorylated rpS6 (Ser240/244, 5364), eIF4A1 (2490), phosphorylated 4E-BP1 (Thr37/46, 9459). From Sigma-Aldrich: VCL (clone hVIN-1 V9131), γtubulin (clone GTU-88 T6557) and acetylated tubulin (T6793). From Spring Bioscience GDI2 (D4-GDI E2430). References for antibodies’ specificity14 (link), 61 (link): for eIF4E and eIF4A162 (link); for eIF3G63 (link), 64 (link); for eIF3B.
Free full text: Click here